+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis



Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis



Journal of Rheumatology 29(1): 62-67



Objective: To investigate the occurrence of extraarticular manifestations (ExRA) in a well defined community based cohort of patients with rheumatoid arthritis (RA), and to examine their effect on mortality. Methods: Using the resources of the Rochester Epidemiology Project, a retrospective medical record review was conducted of a cohort of 424 cases of RA in Olmsted County, MN, USA, diagnosed during the period 1955-1985. These cases had been classified using the American College of Rheumatology 1987 criteria for RA. Patients were followed 1955-1998 (median followup 14.8 yrs; range 0.2-42.8 yrs), and incident ExRA manifestations were recorded according to predefined criteria. Data on comorbidities were extracted using the definitions of the Charlson comorbidity index. Survival was compared to the general population using Kaplan-Meier estimates. Results: ExRA occurred in 169 patients, corresponding to an incidence rate of 3.67/100 person-yrs. Compared to the general population, survival among patients with RA was decreased. Survival among patients with ExRA was markedly decreased compared to the general population and to patients without ExRA (p<0.001). A particularly poor prognosis was noted in a subgroup of 63 patients (incidence rate 1.04/100 person-yrs) who fulfilled predefined criteria for severe ExRA (i.e., vasculitis, pericarditis, pleuritis, and/or Felty's syndrome). For RA patients who did not fulfill these criteria, there was no significant increase of mortality (p=0.09). In a multivariate model of mortality, including age, sex, and the presence of known comorbidities, the presence of one or more of these ExRA was the strongest predictor of mortality. Conclusion: In this first community based study of extraarticular manifestations in RA, virtually all the excess mortality occurred in a subgroup of patients with severe extraarticular disease, suggesting that extraarticular disease is the major predictor of mortality in patients with RA.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 011082240

Download citation: RISBibTeXText

PMID: 11824973


Related references

Severe Extraarticular Manifestations in a Community-based Cohort of Patients with Rheumatoid Arthritis: Risk Factors and Incidence in Relation to Treatment with Tumor Necrosis Factor Inhibitors. Journal of Rheumatology 44(7): 981-987, 2017

Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Medicine 92(2): 92-97, 2013

No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis and Rheumatism 50(11): 3729-3731, 2004

Some aspects of occurrence of serious extraarticular manifestations of rheumatoid arthritis. Anon Abstracta Xii Congressus Rheumatologicus Internationalis Praga (Abstracts 12th International Rheumatological Congress ) Np J R Geigy S A : basle, Switz 221, 1969

HLA-DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestations. European Journal of Immunogenetics 26(1): 19-27, 1999

Clustering of extraarticular manifestations in patients with rheumatoid arthritis. Journal of Rheumatology 35(1): 179-180, 2008

THU0053No Excess Mortality in A Population-Based Danish Rheumatoid Arthritis Cohort from The Late Pre-Biologic Era: Table 1. Annals of the Rheumatic Diseases 75(Suppl 2): 197.1-197, 2016

Anti-cyclic citrullinated peptide antibody, smoking, alcohol consumption, and disease duration as risk factors for extraarticular manifestations in Korean patients with rheumatoid arthritis. Journal of Rheumatology 35(6): 995-1001, 2008

Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extraarticular disease manifestations. Arthritis and Rheumatism 54(2): 642-648, 2006

Extraarticular Manifestations of Rheumatoid Arthritis in Patients under Anti-tumor Necrosis Factor-α Treatment. Journal of Rheumatology 42(6): 1059, 2016

Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis. Joint, Bone, Spine 85(3): 317-322, 2017

Extraarticular manifestations in Turkish patients with rheumatoid arthritis: impact of EAMs on the health-related quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatology International 32(6): 1521-1525, 2012

Excess mortality from cardiovascular disease in patients with rheumatoid arthritis. Ugeskrift for Laeger 173(5): 343-346, 2011

Influence of HLA-DRB1 and TNF microsatellite polymorphisms on the expression of extraarticular manifestations in rheumatoid arthritis patients from northwest Spain. Clinical and Experimental Rheumatology 19(6): 703-708, 2002

Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--NSAID a possible cause?. Ugeskrift for Laeger 173(11): 837; Author Reply 837, 2011